BiOptix Diagnostics Secures $6,228,202 New Funding Round

  • Feed Type
  • Date
    3/14/2013
  • Company Name
    BiOptix Diagnostics
  • Mailing Address
    1775 38th St. Boulder, CO 80301
  • Company Description
    The company’s mission is to develop its proprietary E-SPR (Enhanced Surface Plasmon Resonance) technology platform for the detection of molecular interactions.
  • Website
    http://www.bioptix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,228,202
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.